Study to Assess the Long-term Safety and Efficacy of Tirabrutinib in Adults With Relapsed/Refractory B-cell Malignancies
Clinical trial NCT02457559 · COMPLETED
Trial details
- NCT number
- NCT02457559
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-10
- Primary completion
- 2020-12-30
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.